Targeting Tumor Cells with Nanoparticles for Enhanced Co-Drug Delivery in Cancer Treatment
Open Access
- 25 August 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (9) , 1327
Abstract
Gastric cancer (GC) is a fatal malignant tumor, and effective therapies to attenuate its progression are lacking. Nanoparticle (NP)-based solutions may enable the design of novel treatments to eliminate GC. Refined, receptor-targetable NPs can selectively target cancer cells and improve the cellular uptake of drugs. To overcome the current limitations and enhance the therapeutic effects, epigallocatechin-3-gallate (EGCG) and low-concentration doxorubicin (DX) were encapsulated in fucoidan and d-alpha-tocopherylpoly (ethylene glycol) succinate-conjugated hyaluronic acid-based NPs for targeting P-selectin-and cluster of differentiation (CD)44-expressing gastric tumors. The EGCG/DX-loaded NPs bound to GC cells and released bioactive combination drugs, demonstrating better anti-cancer effects than the EGCG/DX combination solution. In vivo assays in an orthotopic gastric tumor mouse model showed that the EGCG/DX-loaded NPs significantly increased the activity of gastric tumors without inducing organ injury. Overall, our EGCG/DX-NP system exerted a beneficial effect on GC treatment and may facilitate the development of nanomedicine-based combination chemotherapy against GC in the future.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 107-2221-E-010-004-MY3)
This publication has 49 references indexed in Scilit:
- Combination of Low Concentration of (−)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer in Vitro and in Vivo through Causing Cell Cycle ArrestInternational Journal of Molecular Sciences, 2013
- Antiproliferative Activity of Fucoidan Was Associated with the Induction of Apoptosis and Autophagy in AGS Human Gastric Cancer CellsJournal of Food Science, 2011
- Combination Therapy with Epigallocatechin-3-Gallate and Doxorubicin in Human Prostate Tumor Modeling StudiesThe American Journal of Pathology, 2010
- Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III Randomized, Multicenter, Clinical TrialOncology, 2010
- Fucoidan Induces Apoptosis through Activation of Caspase-8 on Human Breast Cancer MCF-7 CellsJournal of Agricultural and Food Chemistry, 2009
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44Stem Cells, 2009
- Variant isoforms of CD44 are P‐ and L‐selectin ligands on colon carcinoma cellsThe FASEB Journal, 2005
- Palliative chemotherapy for advanced gastric cancerAnnals of Oncology, 2004
- Fucoidan inhibits leukocyte recruitment in a model peritonial inflammation in rat and blocks interaction of P‐selectin with its carbohydrate ligandIUBMB Life, 1997
- P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer.Journal of Clinical Investigation, 1993